Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

I-Mab to Start US Phase I Trial of Immunotherapy for Alzheimer's

Zai Lab and Entasis Complete Enrollment in Global Test of New Antibacterial

Innovent Starts China Trial of PD-1/TIGIT Bispecific for Solid Tumors

Ascletis to Start China Phase III Trial of FASN Inhibitor for Brain Cancer

Antengene to Start Trial of PD-L1/4-1BB Bispecific in Solid Tumors and NHL

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021